Trial Profile
A retrospective, observational study of dulaglutide in patients with type 2 diabetes.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 May 2018
Price :
$35
*
At a glance
- Drugs Dulaglutide (Primary) ; Insulin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 23 May 2018 Results assessing Dulaglutide Alone or in Combination with Insulin (n=952) presented at the 23rd Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research
- 24 May 2017 Results (n=734) presented at the 22nd Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research
- 22 May 2017 New trial record